Insulin sensitivity accounts for glucose and lactate kinetics after intravenous glucose injection. 1995

R M Watanabe, and J Lovejoy, and G M Steil, and M DiGirolamo, and R N Bergman
University of Southern California, Department of Exercise Science, USA.

Mathematical modeling was used to explore the interaction between glucose, insulin, and lactate during the frequently sampled intravenous glucose tolerance test (FSIGTT). Insulin-modified FSIGTs were performed in 25 lean volunteers, and an additional 5 volunteers underwent FSIGTs with glucose injection alone to illustrate the effect of insulin on both glucose and lactate kinetics. The model chosen as the best representation of the system extended the minimal model of glucose kinetics (MM) by including a two-compartment model of lactate kinetics. The model accounted for both glucose and lactate kinetics, provided traditional MM parameters of insulin sensitivity and glucose effectiveness, and descriptive parameters of lactate kinetics. Modeling suggested that lactate production was limited by the rate of glucose disappearance, with no indication of direct effects of insulin on lactate. Inclusion of lactate kinetics had no adverse effect on MM parameters (SG: 0.023 +/- 0.009 vs. 0.023 +/- 0.010 min-1, SI: 1.01 +/- 0.70 vs. 1.03 +/- 0.71 x 10(4).min-1.pmol-1.1; P > 0.50, lactate model vs. MM), and indicated that approximately 1.2% min-1 of total glucose disappearance during the FSIGT is converted to lactate. An additional benefit of including lactate kinetics was the significant improvement in precision in MM parameter estimates as reflected by the fractional standard deviations (FSDs). This effect was most prominent for SG, in which a threefold improvement in parameter precision was observed (FSD: 13.5 +/- 3.1 vs. 42.5 +/- 48.5; means +/- SD).(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D007700 Kinetics The rate dynamics in chemical or physical systems.
D007773 Lactates Salts or esters of LACTIC ACID containing the general formula CH3CHOHCOOR.
D008297 Male Males
D008433 Mathematics The deductive study of shape, quantity, and dependence. (From McGraw-Hill Dictionary of Scientific and Technical Terms, 6th ed) Mathematic
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D005260 Female Females

Related Publications

R M Watanabe, and J Lovejoy, and G M Steil, and M DiGirolamo, and R N Bergman
June 1992, Presse medicale (Paris, France : 1983),
R M Watanabe, and J Lovejoy, and G M Steil, and M DiGirolamo, and R N Bergman
October 1996, Nihon rinsho. Japanese journal of clinical medicine,
R M Watanabe, and J Lovejoy, and G M Steil, and M DiGirolamo, and R N Bergman
February 1977, The American journal of physiology,
R M Watanabe, and J Lovejoy, and G M Steil, and M DiGirolamo, and R N Bergman
October 2004, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism,
R M Watanabe, and J Lovejoy, and G M Steil, and M DiGirolamo, and R N Bergman
March 1954, The Journal of clinical investigation,
R M Watanabe, and J Lovejoy, and G M Steil, and M DiGirolamo, and R N Bergman
July 1979, The Journal of clinical investigation,
R M Watanabe, and J Lovejoy, and G M Steil, and M DiGirolamo, and R N Bergman
July 1984, Endocrinology,
R M Watanabe, and J Lovejoy, and G M Steil, and M DiGirolamo, and R N Bergman
May 2011, Theoretical biology & medical modelling,
R M Watanabe, and J Lovejoy, and G M Steil, and M DiGirolamo, and R N Bergman
January 1991, Reproduction, nutrition, development,
R M Watanabe, and J Lovejoy, and G M Steil, and M DiGirolamo, and R N Bergman
January 1992, Metabolism: clinical and experimental,
Copied contents to your clipboard!